Peptide-Targeted Nanoparticles Dramatically Improve Glioblastoma Treatment in Mice
Exploiting the potential of
Background
Glioblastoma multiforme (GBM) is an aggressive and highly lethal brain cancer with a dismal prognosis, largely due to the blood-brain barrier (BBB), a protective physiological structure that severely limits drug delivery to the tumor site. Current standard-of-care therapies often fail to achieve sufficient therapeutic concentrations within the tumor, leading to rapid recurrence and poor patient outcomes. This study explores novel strategies to enhance drug penetration across the BBB and achieve targeted delivery to GBM cells, aiming to improve treatment efficacy.